Brainreader A/S, the Denmark based brain health and analytic software company announced today that company founder and Chief Science Officer Dr. Jamila Ahdidan has transitioned to Danish Visiopharm as their Clinical Project Manager. Ms. Ahdidan resigned from Brainreader, creator of the Neuroreader® volumetric software, effective March 31, 2022.

Thor Birkmand, Brainreader Chairman said, “Jamila brought tremendous science, intelligence and vision to the company throughout its early years, and we are excited for her in this new undertaking. She continues on the Brainreader board of directors, and we expect to benefit from her smart scientific thinking going forward.”

Founded in 2011, Brainreader is an industry leader in brain volumetrics, growing rapidly in the U.S. market, and expanding its scientific and commercial staff, under the leadership of CEO Mads Fiig. “Jamila is an engaging, forward thinking and accomplished scientist.

Brainreader has recently committed to expanding its personnel and resources as it deepens its presence in the North American market, building on already established Neuroreader® hubs at a number of prominent MRI clinics and universities across the country.